P Arbuckle
Chief Executive Officer / Donaco International
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 736th | Tryptamine Therapeutics | 18.97% | -36.42% |
| 737th | Microequities Asset Management Group | 18.91% | 11.54% |
| 738th | Donaco International | 18.9% | -11.97% |
| 739th | RocketDNA | 18.9% | -11.97% |
| 740th | AUB Group | 18.79% | 20.78% |
|
NEW ROLE: Chief Executive Officer, Donaco International | 24 Nov 2020 |
Access to our data for P Arbuckle is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
P Arbuckle is linked to 1 organisation which is included in 1 list - Public Companies - non WA.
To see the data you will need to Subscribe.